Summary
Dr. Massimo Gadina is the Director of the Office of Science and Technology (OST) at the NIAMS, supporting intramural researchers with core technologies. He also serves as Chief of the Translational Immunology Section of the OST. Prior to this appointment, he was Senior Lecturer at the Division of Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, The Queen's University of Belfast, Northern Ireland.
Research Statement
Dr. Gadina's research interests are focused on immune-mediated diseases and specifically, the biology of cytokines and their relative signaling pathways. His translational work is also focused on autoinflammatory diseases and other inflammatory diseases.
Scientific Publications
Education
Università di Milano, Italy
Doctor of Pharmaceutical Chemistry and Technology
Université de Bourgogne, Dijon, France
Diplôme de Docteur
Experience
Director, Office of Science and Technology
Chief, Translational Immunology Section
NIAMS, NIH, 2009 - present
Staff Scientist, Acting Director, Office of Science and Technology
Acting Chief Translational Immunology Section
NIAMS, NIH, 2008 - 2009
Senior Lecturer, Tenured
Division of Infection and Immunity, School of Medicine Dentistry and Biomedical Sciences, The Queen’s University of Belfast, Northern Ireland, U.K., 2003 - 2008
Staff Scientist
Lymphocyte Cell Biology Section, Arthritis and Rheumatism Branch, NIAMS, NIH, 2000 - 2002
Visiting Associate
Lymphocyte Cell Biology Section, Arthritis and Rheumatism Branch, NIAMS, NIH, 1996 - 1999
Research Associate-Staff Scientist
Division of Experimental Oncology E, Istituto Nazionale per lo Studio e la Cura dei Tumori,Milano, Italy, 1990 - 1996.